Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.167 Telemedicine for out-patient management of adult asthma patients, effect on quality of life and asthma control, a randomised control trial. Dr. KO Fanny Wai San
古惠珊
2022.168 Instant message-delivered brief Internet-based Cognitive Behavioural Therapy (iCBT) for post-stroke depression: a mixed method study Dr. TANG Maria Wing Sze
2022.169 The use of JAK-1/3 inhibitor (Tofacitinib) in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis – A pilot study Dr. CHAN Agnes Wai Sze
陳慧詩醫生
2022.170 A prospective cross-sectional multi-center study to assess the diagnostic accuracy of a panel of bacterial gene markers (M3) for colorectal advanced neoplasia Prof. LAU Louis Ho Shing
柳浩城
2022.171 A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL) Dr. WONG Raymond Siu Ming
王紹明
2022.172 KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer Dr. LOONG Herbert Ho Fung
龍浩鋒醫生
2022.173 EPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation Prof. YEO Winnie
楊明明教授
2022.174 AN OPEN LABEL, RANDOMISED, PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MTL-CEBPA ADMINISTERED IN COMBINATION WITH SORAFENIB OR SORAFENIB ALONE, IN TKI NAÏVE PARTICIPANTS WITH PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA (HCC) AND HEPATITIS B OR HEPATITIS C VIRUS (OUTREACH2) Prof. CHAN Stephen Lam
陳林
2022.175 Sequential TransArterial chemoembolization and stereotactic RadioTherapy Followed by Durvalumab (MEDI4736) and Tremelimumab for downstaging hepatocellular carcinoma for hepatectomy Prof. CHAN Stephen Lam
陳林醫生
2022.176 Change in chronic low back pain participant trunk and lower limb kinematics after structural exercise program Mr. SUTANTO Dhananjaya
2022.178 Enhancing global self-esteem of breast cancer survivors: a randomized controlled trial Prof. CHAIR Sek Ying
2022.179 Efficacy of digitally delivered and face-to-face group cognitive behavioural therapy for insomnia in pregnant women with comorbid insomnia and depression: A randomised controlled trial Dr. CHAN Joey Wing Yan
2022.180 Melanopsin-mediated pupillary response in patients with rapid eye movement sleep behaviour disorder Dr. CHAN Joey Wing Yan
2022.181 Evaluation the effects of an online sleep and mood intervention in adults recovered from COVID-19 Dr. CHAN Ngan Yin
陳銀燕
2022.182 A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Prof. NG Chi Fai
吳志輝
2022.183 Online Mindfulness-based Intervention to Enhance Bracing Compliance for Adolescent Idiopathic Scoliosis (AIS) – A Pilot Randomized Single-blinded Controlled Trial Prof. LAM Tsz Ping
林子平
2022.184 Efficacy and Safety of an innovative Chinese Herbal formular for the Treatment of Gout: A Double-blind, Randomized, Placebo-Controlled Trial 一個創新中藥方劑作為治療痛風症之療效及安全性研究:隨機、雙盲、安慰劑對照臨床試驗 Prof. LIN Zhixiu
林志秀
2022.185 A double-blinded, randomised controlled trial to investigate the treatment effects of pulsed electromagnetic field (PEMF) on end stage of Knee Osteoarthritis Prof. ONG Michael Tim Yun
王添欣
2022.186 A Double-Blinded, Randomized-Controlled-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) on quadriceps muscle strength for patients at 2 months after Anterior Cruciate Ligament Reconstruction (ACLR) Prof. ONG Michael Tim Yun
王添欣
2022.187 Perception towards breastfeeding training from midwives in mainland China: An exploratory qualitative study Ms. WANG Tianci
王 天 慈
2022.188 Online Temporal Processing Assessment and Training for Children Prof. CHAN Agnes Sui Yin
陳瑞燕
2022.189 Low-level Laser Therapy Alleviates Osteoarthritis Progression Prof. QIN Ling
秦嶺
2022.190 Individual patient data meta-analysis of medical treatment with timed surgery compared to immediate surgery in patients with acute type A intramural hematoma Dr. CHOW Simon Chi Ying
2022.191 Endovascular Embolization of Cerebral Arteriovenous Malformation, Cerebral Aneurysms, Dural Arteriovenous Fistula, and other Vascular Pathologies in Neurosurgery Dr. CHEUNG Yuk Hong Eric
2022.192 Pictorial Essay: Molecular classification and respective radiological phenotype of breast cancer Dr. YU Suet Mui
于雪梅
2022.193 A Pilot Study of Transforming the Prognosis and Care of Scoliosis with Artificial Intelligence (AI) assisted Curve Surveillance Prof. LEE Wayne Yuk Wai
2022.194 Clinical outcome of Territory-wide Prehospital Stroke Notification in Hong Kong Dr. IP Bonaventure Yiu Ming
葉曜明
2022.195 Individual Barriers & Reacceptance to Metabolic and Bariatric Surgery in Chinese Morbid Obesity Patients Dr. NG Stephen Ka Kei
吳家琦
2022.196 Genetic Landscape of Paediatric Idiopathic Steroid-Resistant Nephrotic Syndrome (SRNS) and Congenital or Infantile Nephrotic Syndrome (NS) in Hong Kong: A Retrospective Review Dr. CHEUNG Hon Ming
2022.197 Excess all-cause mortality during the COVID-19 pandemic in Hong Kong: A time series analysis using territory-wide hospitalization data Dr. CHONG Ka Chun
2022.198 An audit of clinical outcomes of otology and neurotology surgeries in Hong Kong Dr. NG Iris Hoi Yee
伍凱怡
2022.199 Deep learning and radiomics algorithm of neuroimaging for TED in Hong Kong – A territory-wide study from the HADCL Dr. CHONG Kelvin Kam Lung
莊金隆
2022.200 Right ventricular systolic dysfunction predicts poor outcomes after tricuspid valve surgery Prof. LEE Alex Pui Wai
2022.201 Territory-wide Retrospective Cohort Review of Paediatric Cardiomyopathy in Hong Kong Dr. SO Enoch Chi Tak
2022.202 Real world analysis of sequencing of systemic treatment in hepatocellular carcinoma Prof. CHAN Stephen L.
陳林
2022.203 Altered gut microbiome composition by appendectomy contributes to colorectal cancer Prof. YU Jun
于君
2022.204 Evalution of the Progression of Disease and Health-related Quality of Life in Ambulatory Heart Failure Patients: A local clinic-based registry Prof. TAN Guang Ming
譚廣明
2022.205 Retrospective review on paediatric and adolescent adnexal masses Dr. NG Karen
吳嘉詠
2022.206 The Relation Between Glycemic Variability on Renal Mitochondrial Injury in Diabetic Kidney Disease Prof. SZETO Cheuk Chun
司徒卓俊
2022.207 The impact of early-life exposure to metabolic abnormalities on pubertal development - from epidemiological analyses to mechanisms Prof. MA Ronald Ching Wan
馬青雲
2022.208 Clinical and prognostic significance of intrahepatic fibroblast activation protein expression in patients with non-alcoholic fatty liver disease Dr. WONG Vincent
黃煒燊
2022.209 Impact of early dose intensity reduction of Palbociclib and Ribociclib on clinical outcomes in patients with hormone-receptor positive, human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer in the first-line setting Dr. FENG Ye
馮燁
2022.211 Managment of Elderly Breast Cancer Patients - Surgery versus Conservative - a Retrospective Cohort in Hong Kong Dr. CHEUNG Alyson
張洛頤
2022.212 Impacts of COVID-19 vaccination on the ocular surface microbiota, cornea, uvea, macular vasculature and vision in children Prof. YAM Jason Cheuk Sing
2022.213 Validation of C19-YRS in diagnosis of Long COVID syndrome in Chinese Dr. FAN Florence Sin Ying
樊倩英
2022.215 Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease: A Multicentre, Randomized, Double-masked, Placebo-controlled Clinical Trial Dr. CHONG Kam Lung
莊金隆
2022.216 A Phase 1/2, Safety Confirmation, Placebo-controlled, Randomized Study of Nivolumab in Combination with Relatlimab and Bevacizumab in Treatment-naive Advanced/Metastatic Hepatocellular Carcinoma (RELATIVITY-106) Prof. CHAN Stephen Lam
陳林
2022.217 EUS-guided trans-papillary or trans-luminal biliary stenting for malignant biliary obstruction: A prospective randomised comparison. Prof. TEOH Anthony Yuen Bun
張源斌
2022.218 A Pilot Study on Portable Surface Scanner Prof. LAW Sheung Wai
2022.219 Sensorimotor Block Dynamics and Hemidiaphragmatic Palsy: A Randomized Superiority Trial Comparing Selective Trunk Block and Supraclavicular Brachial Plexus Block. Prof. KARMAKAR Manoj
高文佳

Page 223 of 254.